AZithromycin Against pLacebo in Exacerbations of Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Asthma
Interventions
DRUG

Zithromax

250mg \* 2 capsules once daily for three days

DRUG

Placebo

Lactose powder

Trial Locations (14)

S75 2EP

Barnsley Hospital NHS Foundation, Barnsley

CH2 1UL

Countess of Chester Hospital NHS Foundation Trust, Liverpool

RH1 5RH

Surrey & Sussex Healthcare NHS Trust, Redhill

B9 5SS

Heart of England NHS Foundation Trust, Birmingham

FY3 8NR

Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool

G12 0YN

University of Glasgow, Glasgow

LE39QP

University Hospitals of Leicester NHS Foundation Trust, Leicester

W2 1PG

Imperial College Healthcare NHS Trust, London

M23 9QZ

University Hospital of South Manchester Foundation Trust, Manchester

NE7 7DN

Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle

NG5 1PB

Nottingham University Hospitals NHS Trust, Nottingham

PO6 3LY

Portsmouth Hospitals NHS Trust, Portsmouth

TS19 8PE

University Hospital of North Tees, Stockton-on-Tees

NG17 4JL

Sherwood Forest Hospitals NHS Foundation Trust, Sutton in Ashfield

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Imperial College London

OTHER

NCT01444469 - AZithromycin Against pLacebo in Exacerbations of Asthma | Biotech Hunter | Biotech Hunter